Does INSULIN GLARGINE Cause Inappropriate schedule of product administration? 8,982 Reports in FDA Database

Q: Does INSULIN GLARGINE cause Inappropriate schedule of product administration?

8,982 reports of Inappropriate schedule of product administration have been filed with the FDA for INSULIN GLARGINE, representing 9.0% of all INSULIN GLARGINE adverse event reports.

Q: How dangerous is Inappropriate schedule of product administration from INSULIN GLARGINE?

Of 8,982 reports, 32 (0.4%) resulted in death and 518 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8,982 reports of Inappropriate schedule of product administration have been filed in association with INSULIN GLARGINE (Lantus Solostar). This represents 9.0% of all adverse event reports for INSULIN GLARGINE.

8,982

Reports of Inappropriate schedule of product administration with INSULIN GLARGINE

9.0%

of all INSULIN GLARGINE reports

Deaths

518

Hospitalizations

How Dangerous Is Inappropriate schedule of product administration From INSULIN GLARGINE?

Of the 8,982 reports, 32 (0.4%) resulted in death, 518 (5.8%) required hospitalization, and 25 (0.3%) were considered life-threatening.

Is Inappropriate schedule of product administration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INSULIN GLARGINE. However, 8,982 reports have been filed with the FAERS database.

What Other Side Effects Does INSULIN GLARGINE Cause?

Blood glucose increased (19,234) Product storage error (7,743) Off label use (6,842) Visual impairment (5,793) Blood glucose decreased (4,552) Drug ineffective (4,351) Hypoglycaemia (4,212) Injection site pain (3,574) Device issue (3,175) Incorrect dose administered (3,070)

What Other Drugs Cause Inappropriate schedule of product administration?

ADAPALENE (16,473) DUPILUMAB (14,927) AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,546) INFLIXIMAB (6,847) INFLIXIMAB-DYYB (5,977) SECUKINUMAB (4,817) DULAGLUTIDE (3,606) VEDOLIZUMAB (3,259) SACUBITRIL\VALSARTAN (2,870) ACETAMINOPHEN (2,248)

Which INSULIN GLARGINE Alternatives Have Lower Inappropriate schedule of product administration Risk?

INSULIN GLARGINE vs INSULIN GLARGINE-YFGN INSULIN GLARGINE vs INSULIN GLARGINE\LIXISENATIDE INSULIN GLARGINE vs INSULIN GLULISINE INSULIN GLARGINE vs INSULIN HUMAN INSULIN GLARGINE vs INSULIN LISPRO

INSULIN GLARGINE Full Profile All Inappropriate schedule of product administration Reports All Drugs Causing Inappropriate schedule of product administration INSULIN GLARGINE Demographics